Dystrophins, utrophins, and associated scaffolding complexes: Role in mammalian brain and implications for therapeutic strategies

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  Perronnet, Caroline ^a,b   Vaillend, Cyrille ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DEFLAZACORT; DYSTROPHIN; DYSTROPHIN ASSOCIATED GLYCOPROTEIN COMPLEX; DYSTROPHIN ASSOCIATED PROTEIN COMPLEX; GENE PRODUCT; PREDNISOLONE; SOMATOMEDIN; UNCLASSIFIED DRUG; UTROPHIN;

BLOOD BRAIN BARRIER; BRAIN DEVELOPMENT; CELL THERAPY; COGNITIVE DEFECT; CYTOSKELETON; DUCHENNE MUSCULAR DYSTROPHY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE STRUCTURE; GENE TRANSFER; GENOTYPE PHENOTYPE CORRELATION; HUMAN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REVIEW; STEROID THERAPY; ANIMAL; BRAIN; CHEMISTRY; GENETICS; MAMMAL; METABOLISM;

MAMMALIA;

ANIMALS; BRAIN; COGNITION DISORDERS; DYSTROPHIN; HUMANS; MAMMALS; MUSCULAR DYSTROPHY, DUCHENNE; UTROPHIN;

EID: 77954545973     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/849426     Document Type: Review

References (205)

1. Hoffman E. P., Brown R. H. Jr., Kunkel L. M., Dystrophin: the protein product of the Duchenne muscular dystrophy locus Cell 1987 51 6 919 928
2. Hinton V. J., De Vivo B. C., Nereo N. E., Goldstein E., Stern Y., Poor verbal working memory across intellectual level in boys with Duchenne dystrophy Neurology 2000 54 11 2127 2132
3. Desguerre I., Christov C., Mayer M., Clinical heterogeneity of Duchenne muscular dystrophy (DMD): definition of sub-phenotypes and predictive criteria by long-term follow-up PloS One 2009 4 2, article e4347
4. Blake D. J., Weir A., Newey S. E., Davies K. E., Function and genetics of dystrophin and dystrophin-related proteins in muscle Physiological Reviews 2002 82 2 291 329
5. Haenggi T., Fritschy J.-M., Role of dystrophin and utrophin for assembly and function of the dystrophin glycoprotein complex in non-muscle tissue Cellular and Molecular Life Sciences 2006 63 14 1614 1631
6. Pilgram G. S. K., Potikanond S., Baines R. A., Fradkin L. G., Noordermeer J. N., The roles of the dystrophin-associated glycoprotein complex at the synapse Molecular Neurobiology 2010 41 1 1 21
7. Billard C., Gillet P., Signoret J. L., Cognitive functions in duchenne muscular dystrophy: a reappraisal and comparison with spinal muscular atrophy Neuromuscular Disorders 1992 2 5-6 371 378
8. Cotton S., Voudouris N. J., Greenwood K. M., Intelligence and Duchenne muscular dystrophy: full-scale, verbal, and performance intelligence quotients Developmental Medicine and Child Neurology 2001 43 7 497 501
9. Billard C., Gillet P., Barthez M.-A., Hommet C., Bertrand P., Reading ability and processing in Duchenne muscular dystrophy and spinal muscular atrophy Developmental Medicine and Child Neurology 1998 40 1 12 20
10. Roccella M., Pace R., De Gregorio M. T., Psychopathological assessment in children affected by Duchenne de Boulogne muscular dystrophy Minerva Pediatrica 2003 55 3 267 276
11. Hinton V. J., De Vivo D. C., Nereo N. E., Goldstein E., Stern Y., Selective deficits in verbal working memory associated with a known genetic etiology: the neuropsychological profile of Duchenne muscular dystrophy Journal of the International Neuropsychological Society 2001 7 1 45 54
12. Hendriksen J. G. M., Vles J. S. H., Neuropsychiatric disorders in males with duchenne muscular dystrophy: frequency rate of attention-deficit hyperactivity disorder (ADHD), autism spectrum disorder, and obsessive-compulsive disorder Journal of Child Neurology 2008 23 5 477 481
13. Hinton V. J., Nereo N. E., Fee R. J., Cyrulnik S. E., Social behavior problems in boys with Duchenne muscular dystrophy Journal of Developmental and Behavioral Pediatrics 2006 27 6 470 476
14. Hinton V. J., Fee R. J., De Vivo D. C., Goldstein E., Poor facial affect recognition among boys with Duchenne muscular dystrophy Journal of Autism and Developmental Disorders 2007 37 10 1925 1933
15. Donders J., Taneja C., Neurobehavioral characteristics of children with duchenne muscular dystrophy Child Neuropsychology 2009 15 3 295 304
16. Cyrulnik S. E., Hinton V. J., Duchenne muscular dystrophy: a cerebellar disorder? Neuroscience and Biobehavioral Reviews 2008 32 3 486 496
17. Lidov H. G. W., Byers T. J., Kunkel L. M., The distribution of dystrophin in the murine central nervous system: an immunocytochemical study Neuroscience 1993 54 1 167 187
18. Rapaport D., Passos-Bueno M. R., Brandao L., Love D., Vainzof M., Zatz M., Apparent association of mental retardation and specific patterns of deletions screened with probes cf56a and cf23a in Duchenne Muscular Dystrophy American Journal of Medical Genetics 1991 39 4 437 441
19. Lenk U., Hanke R., Thiele H., Speer A., Point mutations at the carboxy terminus of the human dystrophin gene: implications for an association with mental retardation in DMD patients Human Molecular Genetics 1993 2 11 1877 1881
20. Moizard M.-P., Billard C., Toutain A., Berret F., Marmin N., Moraine C., Are Dp71 and Dp140 brain dystrophin isoforms related to cognitive impairment in Duchenne muscular dystrophy? American Journal of Medical Genetics 1998 80 1 32 41
21. Moizard M.-P., Toutain A., Fournier D., Severe cognitive impairment in DMD: obvious clinical indication for Dp71 isoform point mutation screening European Journal of Human Genetics 2000 8 7 552 556
22. Felisari G., Boneschi F. M., Bardoni A., Loss of Dp140 dystrophin isoform and intellectual impairment in Duchenne dystrophy Neurology 2000 55 4 559 564
23. Daoud F., Angeard N., Demerre B., Analysis of Dp71 contribution in the severity of mental retardation through comparison of Duchenne and Becker patients differing by mutation consequences on Dp71 expression Human Molecular Genetics 2009 18 20 3779 3794
24. Taylor P. J., Betts G. A., Maroulis S., Dystrophin gene mutation location and the risk of cognitive impairment in duchenne muscular dystrophy PloS One 2010 5 1, article e8803
25. Muntoni F., Torelli S., Ferlini A., Dystrophin and mutations: one gene, several proteins, multiple phenotypes Lancet Neurology 2003 2 12 731 740
26. Nicholson L. V. B., Johnson M. A., Bushby K. M. D., Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 1. Trends across the clinical groups Journal of Medical Genetics 1993 30 9 728 736
27. Rafael J. A., Cox G. A., Corrado K., Jung D., Campbell K. P., Chamberlain J. S., Forced expression of dystrophin deletion constructs reveals structure-function correlations Journal of Cell Biology 1996 134 1 93 102
28. Sadoulet-Puccio H. M., Kunkel L. M., Dystrophin and its isoforms Brain Pathology 1996 6 1 25 35
29. Winder S. J., The membrane-cytoskeleton interface: the role of dystrophin and utrophin Journal of Muscle Research and Cell Motility 1997 18 6 617 629
30. Khurana T. S., Davies K. E., Pharmacological strategies for muscular dystrophy Nature Reviews Drug Discovery 2003 2 5 379 390
31. Luise M., Presotto C., Senter L., Dystrophin is phosphorylated by endogenous protein kinases Biochemical Journal 1993 293 1 243 247
32. Jarrett H. W., Foster J. L., Alternate binding of actin and calmodulin to multiple sites on dystrophin Journal of Biological Chemistry 1995 270 10 5578 5586
33. Senter L., Ceoldo S., Petrusa M. M., Salviati G., Phosphorylation of dystrophin: effects on actin binding Biochemical and Biophysical Research Communications 1995 206 1 57 63
34. Michalak M., Fu S. Y., Milner R. E., Busaan J. L., Hance J. E., Phosphorylation of the carboxyl-terminal region of dystrophin Biochemistry and Cell Biology 1996 74 4 431 437
35. Walsh M. P., Busaan J. L., Fraser E. D., Fu S. Y., Pato M. D., Michalak M., Characterization of the recombinant C-terminal domain of dystrophin: phosphorylation by calmodulin-dependent protein kinase II and dephosphorylation by type 2B protein phosphatase Biochemistry 1995 34 16 5561 5568
36. Rando T. A., The dystrophin-glycoprotein complex, cellular signaling, and the regulation of cell survival in the muscular dystrophies Muscle and Nerve 2001 24 12 1575 1594
37. Carlson C. G., The dystrophinopathies: an alternative to the structural hypothesis Neurobiology of Disease 1998 5 1 3 15
38. Lidov H. G. W., Dystrophin in the nervous system Brain Pathology 1996 6 1 63 77
39. Knuesel I., Bornhauser B. C., Zuellig R. A., Heller F., Schaub M. C., Fritschy J.-M., Differential expression of utrophin and dystrophin in CNS neurons: an in situ hybridization and immunohistochemical study Journal of Comparative Neurology 2000 422 4 594 611
40. Sekiguchi M., Zushida K., Yoshida M., A deficit of brain dystrophin impairs specific amygdala GABAergic transmission and enhances defensive behaviour in mice Brain 2009 132 1 124 135
41. Pillers D.-A. M., Weleber R. G., Green D. G., Effects of dystrophin isoforms on signal transduction through neural retina: genotype-phenotype analysis of Duchenne muscular dystrophy mouse mutants Molecular Genetics and Metabolism 1999 66 2 100 110
42. Costa M. F., Oliveira A. G. F., Feitosa-Santana C., Zatz M., Ventura D. F., Red-green color vision impairment in Duchenne muscular dystrophy American Journal of Human Genetics 2007 80 6 1064 1075
43. Morris G. E., Simmons C., Man N. T., Apo-dystrophins (DP140 and DP71) and dystrophin splicing isoforms in developing brain Biochemical and Biophysical Research Communications 1995 215 1 361 367
44. Lidov H. G. W., Selig S., Kunkel L. M., Dp140: a novel 140 kDa CNS transcript from the dystrophin locus Human Molecular Genetics 1995 4 3 329 335
45. Byers T. J., Lidov H. G. W., Kunkel L. M., An alternative dystrophin transcript specific to peripheral nerve Nature Genetics 1993 4 1 77 81
46. Kim T.-W., Wu K., Xu J.-L., Black I. B., Detection of dystrophin in the postsynaptic density of rat brain and deficiency in a mouse model of Duchenne muscular dystrophy Proceedings of the National Academy of Sciences of the United States of America 1992 89 23 11642 11644
47. Haenggi T., Soontornmalai A., Schaub M. C., Fritschy J.-M., The role of utrophin and Dp71 for assembly of different dystrophin-associated protein complexes (DPCs) in the choroid plexus and microvasculature of the brain Neuroscience 2004 129 2 403 413
48. Gorecki D. C., Barnard E. A., Specific expression of G-dystrophin (Dp71) in the brain NeuroReport 1995 6 6 893 896
49. Aleman V., Osorio B., Chavez O., Rendon A., Mornet D., Martinez D., Subcellular localization of Dp71 dystrophin isoforms in cultured hippocampal neurons and forebrain astrocytes Histochemistry and Cell Biology 2001 115 3 243 254
50. Blake D. J., Hawkes R., Benson M. A., Beesley P. W., Different dystrophin-like complexes are expressed in neurons and glia Journal of Cell Biology 1999 147 3 645 658
51. Daoud F., Candelario-Martinez A., Billard J. M., Role of mental retardation-associated dystrophin-gene product Dp71 in excitatory synapse organization, synaptic plasticity and behavioral functions PloS One 2009 4 8 e6574
52. Tennyson C. N., Klamut H. J., Worton R. G., The human dystrophin gene requires 16 hours to be transcribed and is cotranscriptionally spliced Nature Genetics 1995 9 2 184 190
53. Austin R. C., Howard P. L., D'Souza V. N., Klamut H. J., Ray P. N., Cloning and characterization of alternatively spliced isoforms of Dp71 Human Molecular Genetics 1995 4 9 1475 1483
54. Lidov H. G. W., Kunkel L. M., Dp140: alternatively spliced isoforms in brain and kidney Genomics 1997 45 1 132 139
55. Marquez F. G., Cisneros B., Garcia F., Differential expression and subcellular distribution of dystrophin Dp71 isoforms during differentiation process Neuroscience 2003 118 4 957 966
56. Austin R. C., Morris G. E., Howard P. L., Klamut H. J., Ray P. N., Expression and synthesis of alternatively spliced variants of Dp71 in adult human brain Neuromuscular Disorders 2000 10 3 187 193
57. Austin R. C., Fox J. E. B., Werstuck G. H., Identification of Dp71 isoforms in the platelet membrane cytoskeleton: potential role in thrombin-mediated platelet adhesion Journal of Biological Chemistry 2002 277 49 47106 47113
58. Ceccarini M., Rizzo G., Rosa G., Chelucci C., Macioce P., Petrucci T. C., A splice variant of Dp71 lacking the syntrophin binding site is expressed in early stages of human neural development Developmental Brain Research 1997 103 1 77 82
59. Jin H., Tan S., Hermanowski J., The dystrotelin, dystrophin and dystrobrevin superfamily: new paralogues and old isoforms BMC Genomics 2007 8, article 19
60. Love D. R., Hill D. F., Dickson G., An autosomal transcript in skeletal muscle with homology to dystrophin Nature 1989 339 6219 55 58
61. Tinsley J. M., Blake D. J., Roche A., Primary structure of dystrophin-related protein Nature 1992 360 6404 591 593
62. Buckle V. J., Guenet J. L., Simon-Chazottes D., Love D. R., Davies K. E., Localisation of a dystrophin-related autosomal gene to 6q24 in man, and to mouse chromosome 10 in the region of the dystrophia muscularis (dy) locus Human Genetics 1990 85 3 324 326
63. Prochniewicz E., Henderson D., Ervasti J. M., Thomas D. D., Dystrophin and utrophin have distinct effects on the structural dynamics of actin Proceedings of the National Academy of Sciences of the United States of America 2009 106 19 7822 7827
64. Winder S. J., Gibson T. J., Kendrick-Jones J., Dystrophin and utrophin: the missing links! FEBS Letters 1995 369 1 27 33
65. Dennis C. L., Tinsley J. M., Deconinck A. E., Davies K. E., Molecular and functional analysis of the utrophin promoter Nucleic Acids Research 1996 24 9 1646 1652
66. Burton E. A., Tinsley J. M., Holzfeind P. J., Rodrigues N. R., Davies K. E., A second promoter provides an alternative target for therapeutic up-regulation of utrophin in Duchenne muscular dystrophy Proceedings of the National Academy of Sciences of the United States of America 1999 96 24 14025 14030
67. Khurana T. S., Watkins S. C., Chafey P., Immunolocalization and developmental expression of dystrophin related protein in skeletal muscle Neuromuscular Disorders 1991 1 3 185 194
68. Weir A. P., Burton E. A., Harrod G., Davies K. E., A- and B-utrophin have different expression patterns and are differentially up-regulated in mdx muscle Journal of Biological Chemistry 2002 277 47 45285 45290
69. Tinsley J. M., Davies K. E., Utrophin: a potential replacement for dystrophin? Neuromuscular Disorders 1993 3 5-6 537 539
70. Ohlendieck K., Ervasti J. M., Matsumura K., Kahl S. D., Leveille C. J., Campbell K. P., Dystrophin-related protein is localized to neuromuscular junctions of adult skeletal muscle Neuron 1991 7 3 499 508
71. Rivier F., Robert A., Hugon G., Mornet D., Different utrophin and dystrophin properties related to their vascular smooth muscle distributions FEBS Letters 1997 408 1 94 98
72. Earnest J. P., Santos G. F., Zuerbig S., Fox J. E. B., Dystrophin-related protein in the platelet membrane skeleton. Integrin- induced change in detergent-insolubility and cleavage by calpain in aggregating platelets Journal of Biological Chemistry 1995 270 45 27259 27265
73. Lumeng C. N., Phelps S. F., Rafael J. A., Characterization of dystrophin and utrophin diversity in the mouse Human Molecular Genetics 1999 8 4 593 599
74. Matsumura K., Yamada H., Shimizu T., Campbell K. P., Differential expression of dystrophin, utrophin and dystrophin-associated proteins in peripheral nerve FEBS Letters 1993 334 3 281 285
75. Khurana T. S., Watkins S. C., Kunkel L. M., The subcellular distribution of chromosome 6-encoded dystrophin-related protein in the brain Journal of Cell Biology 1992 119 2 357 366
76. Kamakura K., Tadano Y., Kawai M., Dystrophin-related protein is found in the central nervous system of mice at various developmental stages, especially at the postsynaptic membrane Journal of Neuroscience Research 1994 37 6 728 734
77. Fort P. E., Sene A., Pannicke T., Kir4.1 and AQP4 associate with Dp71- and utrophin-DAPs complexes in specific and defined microdomains of Muller retinal glial cell membrane Glia 2008 56 6 597 610
78. Baby S. M., Bogdanovich S., Willmann G., Basu U., Lozynska O., Khurana T. S., Differential expression of utrophin-A and -B promoters in the central nervous system (CNS) of normal and dystrophic mdx mice Brain Pathology 2010 20 2 323 342
79. Blake D. J., Schofield J. N., Zuellig R. A., G-utrophin, the autosomal homologue of dystrophin Dp116, is expressed in sensory ganglia and brain Proceedings of the National Academy of Sciences of the United States of America 1995 92 9 3697 3701
80. Wilson J., Putt W., Jimenez C., Edwards Y. H., Up71 and Up140, two novel transcripts of utrophin that are homologues of short forms of dystrophin Human Molecular Genetics 1999 8 7 1271 1278
81. Fabbrizio E., Latouche J., Rivier F., Hugon G., Mornet D., Re-evaluation of the distributions of dystrophin and utrophin in sciatic nerve Biochemical Journal 1995 312 1 309 314
82. Zuellig R. A., Bornhauser B. C., Knuesel I., Heller F., Fritschy J.-M., Schaub M. C., Identification and characterisation of transcript and protein of a new short N-terminal utrophin isoform Journal of Cellular Biochemistry 2000 77 3 418 431
83. Jimenez-Mallebrera C., Davies K., Putt W., Edwards Y. H., A study of short utrophin isoforms in mice deficient for full-length utrophin Mammalian Genome 2003 14 1 47 60
84. Roberts R. G., Freeman T. C., Kendall E., Characterization of DRP2, a novel human dystrophin homologue Nature Genetics 1996 13 2 223 226
85. Roberts R. G., Sheng M., Association of dystrophin-related protein 2 (DRP2) with postsynaptic densities in rat brain Molecular and Cellular Neuroscience 2000 16 5 674 685
86. Sherman D. L., Fabrizi C., Gillespie C. Stewart, Brophy P. J., Specific disruption of a Schwann cell dystrophin-related protein complex in a demyelinating neuropathy Neuron 2001 30 3 677 687
87. Blake D. J., Nawrotzki R., Peters M. F., Froehner S. C., Davies K. E., Isoform diversity of dystrobrevin, the murine 87-kDa postsynaptic protein Journal of Biological Chemistry 1996 271 13 7802 7810
88. Ohlendieck K., Characterisation of the dystrophin-related protein utrophin in highly purified skeletal muscle sarcolemma vesicles Biochimica et Biophysica Acta 1996 1283 2 215 222
89. Albrecht D. E., Froehner S. C., Syntrophins and dystrobrevins: defining the dystrophin scaffold at synapses NeuroSignals 2002 11 3 123 129
90. Waite A., Tinsley C. L., Locke M., Blake D. J., The neurobiology of the dystrophin-associated glycoprotein complex Annals of Medicine 2009 41 5 344 359
91. Williamson R. A., Henry M. D., Daniels K. J., Dystroglycan is essential for early embryonic development: disruption of Reichert's membrane in Dag1-null mice Human Molecular Genetics 1997 6 6 831 841
92. Moore S. A., Saito F., Chen J., Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy Nature 2002 418 6896 422 425
93. Muntoni F., Brockington M., Torelli S., Brown S. C., Defective glycosylation in congenital muscular dystrophies Current Opinion in Neurology 2004 17 2 205 209 (Pubitemid 38446465)
94. Glass D. J., Yancopoulos G. D., Sequential roles of agrin, MuSK and rapsyn during neuromuscular junction formation Current Opinion in Neurobiology 1997 7 3 379 384
95. Cavaldesi M., Macchia G., Barca S., Defilippi P., Tarone G., Petrucci T. C., Association of the dystroglycan complex isolated from bovine brain synaptosomes with proteins involved in signal transduction Journal of Neurochemistry 1999 72 4 1648 1655
96. Benson M. A., Newey S. E., Martin-Rendon E., Hawkes R., Blake D. J., Dysbindin, a a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain Journal of Biological Chemistry 2001 276 26 24232 24241
97. Talbot K., Cho D.-S., Ong W.-Y., Dysbindin-1 is a synaptic and microtubular protein that binds brain snapin Human Molecular Genetics 2006 15 20 3041 3054
98. Taneichi-Kuroda S., Taya S., Hikita T., Fujino Y., Kaibuchi K., Direct interaction of Dysbindin with the AP-3 complex via its subunit Neurochemistry International 2009 54 7 431 438
99. Deconinck A. E., Potter A. C., Tinsley J. M., Postsynaptic abnormalities at the neuromuscular junctions of utrophin-deficient mice Journal of Cell Biology 1997 136 4 883 894
100. Grady R. M., Merlie J. P., Sanes J. R., Subtle neuromuscular defects in utrophin-deficient mice Journal of Cell Biology 1997 136 4 871 882
101. Adams M. E., Kramarcy N., Krall S. P., Absence of -syntrophin leads to structurally aberrant neuromuscular synapses deficient in utrophin Journal of Cell Biology 2000 150 6 1385 1398
102. Banks G. B., Fuhrer C., Adams M. E., Froehner S. C., The postsynaptic submembrane machinery at the neuromuscular junction: requirement for rapsyn and the utrophin/dystrophin-associated complex Brain Cell Biology 2003 32 58 709 726
103. Jacobson C., Cote P. D., Rossi S. G., Rotundo R. L., Carbonetto S., The dystroglycan complex is necessary for stabilization of acetylcholine receptor clusters at neuromuscular junctions and formation of the synaptic basement membrane Journal of Cell Biology 2001 153 3 435 450
104. Akaaboune M., Grady R. M., Turney S., Sanes J. R., Lichtman J. W., Neurotransmitter receptor dynamics studied in vivo by reversible photo-unbinding of fluorescent ligands Neuron 2002 34 6 865 876
105. Peter A. K., Marshall J. L., Crosbie R. H., Sarcospan reduces dystrophic pathology: stabilization of the utrophin-glycoprotein complex Journal of Cell Biology 2008 183 3 419 427
106. Peters M. F., Adams M. E., Froehner S. C., Differential association of syntrophin pairs with the dystrophin complex Journal of Cell Biology 1997 138 1 81 93
107. Kramarcy N. R., Sealock R., Syntrophin isoforms at the neuromuscular junction: developmental time course and differential localization Molecular and Cellular Neurosciences 2000 15 3 262 274
108. Pastoret C., Sebille A., mdx mice show progressive weakness and muscle deterioration with age Journal of the Neurological Sciences 1995 129 2 97 105
109. Grady R. M., Wozniak D. F., Ohlemiller K. K., Sanes J. R., Cerebellar synaptic defects and abnormal motor behavior in mice lacking -and -dystrobrevin Journal of Neuroscience 2006 26 11 2841 2851
110. Vaillend C., Billard J.-M., Laroche S., Impaired long-term spatial and recognition memory and enhanced CA1 hippocampal LTP in the dystrophin-deficient Dmdmdx mouse Neurobiology of Disease 2004 17 1 10 20
111. Sesay A. K., Errington M. L., Levita L., Bliss T. V. P., Spatial learning and hippocampal long-term potentiation are not impaired in mdx mice Neuroscience Letters 1996 211 3 207 210
112. Vaillend C., Billard J.-M., Claudepierre T., Rendon A., Dutar P., Ungerer A., Spatial discrimination learning and CA1 hippocampal synaptic plasticity in mdx and mdx(3cv) mice lacking dystrophin gene products Neuroscience 1998 86 1 53 66
113. Muntoni F., Mateddu A., Serra G., Passive avoidance behaviour deficit in the mdx mouse Neuromuscular Disorders 1991 1 2 121 123
114. Vaillend C., Rendon A., Misslin R., Ungerer A., Influence of dystrophin-gene mutation on mdx mouse behavior. I. Retention deficits at long delays in spontaneous alternation and bar-pressing tasks Behavior Genetics 1995 25 6 569 579
115. Vaillend C., Ungerer A., Billard J.-M., Facilitated NMDA receptor-mediated synaptic plasticity in the hippocampal CA1 area of dystrophin-deficient mice Synapse 1999 33 1 59 70
116. Vaillend C., Ungerer A., Behavioral characterization of mdx3cv mice deficient in C-terminal dystrophins Neuromuscular Disorders 1999 9 5 296 304
117. Mehler M. F., Haas K. Z., Kessler J. A., Stanton P. K., Enhanced sensitivity of hippocampal pyramidal neurons from mdx mice to hypoxia-induced loss of synaptic transmission Proceedings of the National Academy of Sciences of the United States of America 1992 89 6 2461 2465
118. Carretta D., Santarelli M., Vanni D., Cortical and brainstem neurons containing calcium-binding proteins in a murine model of Duchenne's muscular dystrophy: selective changes in the sensorimotor cortex Journal of Comparative Neurology 2003 456 1 48 59
119. Miranda R., Sebrie C., Degrouard J., Reorganization of inhibitory synapses and increased PSD length of perforated excitatory synapses in hippocampal area CA1 of dystrophin-deficient mdx mice Cerebral Cortex 2009 19 4 876 888
120. Anderson J. L., Head S. I., Morley J. W., Long-term depression is reduced in cerebellar Purkinje cells of dystrophin-deficient mdx mice Brain Research 2004 1019 1-2 289 292
121. Anderson J. L., Morley J. W., Head S. I., Enhanced homosynaptic LTD in cerebellar Purkinje cells of the dystrophic mdx mouse Muscle and Nerve 2010 41 3 329 334
122. Anderson J. E., A role for nitric oxide in muscle repair: nitric oxide-mediated activation of muscle satellite cells Molecular Biology of the Cell 2000 11 5 1859 1874
123. D'Angelo M. G., Bresolin N., Cognitive impairment in neuromuscular disorders Muscle and Nerve 2006 34 1 16 33
124. Brunig I., Suter A., Knuesel I., Luscher B., Fritschy J.-M., GABAergic terminals are required for postsynaptic clustering of dystrophin but not of GABAA receptors and gephyrin Journal of Neuroscience 2002 22 12 4805 4813
125. Levi S., Grady R. M., Henry M. D., Campbell K. P., Sanes J. R., Craig A. M., Dystroglycan is selectively associated with inhibitory GABAergic synapses but is dispensable for their differentiation Journal of Neuroscience 2002 22 11 4274 4285
126. Knuesel I., Mastrocola M., Zuellig R. A., Bornhauser B., Schaub M. C., Fritschy J.-M., Altered synaptic clustering of GABAA receptors in mice lacking dystrophin (mdx mice) European Journal of Neuroscience 1999 11 12 4457 4462
127. Fritschy J.-M., Schweizer C., Brunig I., Luscher B., Pre- and post-synaptic mechanisms regulating the clustering of type A -aminobutyric acid receptors (GABAA receptors) Biochemical Society Transactions 2003 31 4 889 892
128. Craig A. M., Kang Y., Neurexin-neuroligin signaling in synapse development Current Opinion in Neurobiology 2007 17 1 43 52
129. Knuesel I., Zuellig R. A., Schaub M. C., Fritschy J.-M., Alterations in dystrophin and utrophin expression parallel the reorganization of GABAergic synapses in a mouse model of temporal lobe epilepsy European Journal of Neuroscience 2001 13 6 1113 1124
130. Anderson J. L., Head S. I., Morley J. W., Altered inhibitory input to Purkinje cells of dystrophin-deficient mice Brain Research 2003 982 2 280 283
131. Vaillend C., Billard J.-M., Facilitated CA1 hippocampal synaptic plasticity in dystrophin-deficient mice: role of GABAA receptors? Hippocampus 2002 12 6 713 717
132. Kueh S. L. L., Head S. I., Morley J. W., GABA A receptor expression and inhibitory post-synaptic currents in cerebellar Purkinje cells in dystrophin-deficient mdx mice Clinical and Experimental Pharmacology and Physiology 2008 35 2 207 210
133. Graciotti L., Minelli A., Minciacchi D., Procopio A., Fulgenzi G., GABAergic miniature spontaneous activity is increased in the CA1 hippocampal region of dystrophic mdx mice Neuromuscular Disorders 2008 18 3 220 226
134. Del Tongo C., Carretta D., Fulgenzi G., Catini C., Minciacchi D., Parvalbumin-positive GABAergic interneurons are increased in the dorsal hippocampus of the dystrophic mdx mouse Acta Neuropathologica 2009 118 6 803 812
135. Yoshihara Y., Onodera H., Iinuma K., Itoyama Y., Abnormal kainic acid receptor density and reduced seizure susceptibility in dystrophin-deficient mdx mice Neuroscience 2003 117 2 391 395
136. De Sarro G., Ibbadu G. F., Marra R., Seizure susceptibility to various convulsant stimuli in dystrophin-deficient mdx mice Neuroscience Research 2004 50 1 37 44 (Pubitemid 39024300)
137. Coccurello R., Castellano C., Paggi P., Mele A., Oliverio A., Genetically dystrophic mdx/mdx mice exhibit decreased response to nicotine in passive avoidance NeuroReport 2002 13 9 1219 1222
138. Del Signore A., Gotti C., De Stefano M. E., Moretti M., Paggi P., Dystrophin stabilizes 3- but not 7-containing nicotinic acetylcholine receptor subtypes at the postsynaptic apparatus in the mouse superior cervical ganglion Neurobiology of Disease 2002 10 1 54 66
139. Nico B., Frigeri A., Nicchia G. P., Severe alterations of endothelial and glial cells in the blood-brain barrier of dystrophic mdx mice Glia 2003 42 3 235 251
140. Nico B., Nicchia G. P., Frigeri A., Altered blood-brain barrier development in dystrophic MDX mice Neuroscience 2004 125 4 921 935
141. Nico B., Corsi P., Ria R., Increased matrix-metalloproteinase-2 and matrix-metalloproteinase-9 expression in the brain of dystrophic mdx mouse Neuroscience 2006 140 3 835 848
142. Nico B., Mangieri D., Crivellato E., HIF activation and VEGF overexpression are coupled with ZO-1 up-phosphorylation in the brain of dystrophic MDX mouse Brain Pathology 2007 17 4 399 406
143. Baydur A., Gilgoff I., Prentice W., Carlson M., Fischer D. A., Decline in respiratory function and experience with long-term assisted ventilation in advanced Duchenne's muscular dystrophy Chest 1990 97 4 884 889
144. Sarig R., Mezger-Lallemand V., Gitelman I., Targeted inactivation of Dp71, the major non-muscle product of the DMD gene: differential activity of the Dp71 promoter during development Human Molecular Genetics 1999 8 1 1 10
145. Vaillend C., Poirier R., Laroche S., Genes, plasticity and mental retardation Behavioural Brain Research 2008 192 1 88 105
146. Amiry-Moghaddam M., Xue R., Haug F. M., Alpha-syntrophin deletion removes the perivascular but not endothelial pool of aquaporin-4 at the blood-brain barrier and delays the development of brain edema in an experimental model of acute hyponatremia FASEB Journal 2004 18 3 542 544
147. Vajda Z., Pedersen M., Fuchtbauer E.-M., Delayed onset of brain edema and mislocalization of aquaporin-4 in dystrophin-null transgenic mice Proceedings of the National Academy of Sciences of the United States of America 2002 99 20 13131 13136
148. Nicchia G. P., Rossi A., Nudel U., Svelto M., Frigeri A., Dystrophin-dependent and -independent AQP4 pools are expressed in the mouse brain Glia 2008 56 8 869 876
149. Hibino H., Fujita A., Iwai K., Yamada M., Kurachi Y., Differential assembly of inwardly rectifying K+ channel subunits, Kir4.1 and Kir5.1, in brain astrocytes Journal of Biological Chemistry 2004 279 42 44065 44073
150. Connors N. C., Adams M. E., Froehner S. C., Kofuji P., The potassium channel Kir4.1 associates with the dystrophin-glycoprotein complex via -syntrophin in glia Journal of Biological Chemistry 2004 279 27 28387 28392
151. Guadagno E., Moukhles H., Laminin-induced aggregation of the inwardly rectifying potassium channel, Kir4.1, and the water-permeable channel, AQP4, via a dystroglycan-containing complex in astrocytes Glia 2004 47 2 138 149
152. Sene A., Tadayoni R., Pannicke T., Functional implication of Dp71 in osmoregulation and vascular permeability of the retina PloS One 2009 4 10, article e7329
153. Dalloz C., Sarig R., Fort P., Targeted inactivation of dystrophin gene product Dp71: phenotypic impact in mouse retina Human Molecular Genetics 2003 12 13 1543 1554
154. Benabdesselam R., Sene A., Raison D., A deficit of brain dystrophin 71 impairs hypothalamic osmostat Journal of Neuroscience Research 2010 88 2 324 334
155. Saadoun S., Tait M. J., Reza A., AQP4 gene deletion in mice does not alter blood-brain barrier integrity or brain morphology Neuroscience 2009 161 3 764 772
156. Gorecki D. C., Lukasiuk K., Szklarczyk A., Kaczmarek L., Kainate-evoked changes in dystrophin messenger RNA levels in the rat hippocampus Neuroscience 1998 84 2 467 477
157. Ceccarini M., Macioce P., Panetta B., Petrucci T. C., Expression of dystrophin-associated proteins during neuronal differentiation of P19 embryonal carcinoma cells Neuromuscular Disorders 2002 12 1 36 48
158. Cerna J., Cerecedo D., Ortega A., Dystrophin Dp71f associates with the 1-integrin adhesion complex to modulate PC12 cell adhesion Journal of Molecular Biology 2006 362 5 954 965
159. Deconinck A. E., Rafael J. A., Skinner J. A., Utrophin-dystrophin- deficient mice as a model for Duchenne muscular dystrophy Cell 1997 90 4 717 727
160. Grady R. M., Teng H., Nichol M. C., Cunningham J. C., Wilkinson R. S., Sanest J. R., Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy Cell 1997 90 4 729 738
161. Knuesel I., Riban V., Zuellig R. A., Increased vulnerability to kainate-induced seizures in utrophin-knockout mice European Journal of Neuroscience 2002 15 9 1474 1484
162. Culligan K., Glover L., Dowling P., Ohlendieck K., Brain dystrophin-glycoprotein complex: persistent expression of beta-dystroglycan, impaired oligomerization of Dp71 and up-regulation of utrophins in animal models of muscular dystrophy BMC Cell Biology 2001 2, article 2
163. Hnia K., Tuffery-Giraud S., Vermaelen M., Pathological pattern of Mdx mice diaphragm correlates with gradual expression of the short utrophin isoform Up71 Biochimica et Biophysica Acta 2006 1762 3 362 372
164. Bogdanovich S., Perkins K. J., Krag T. O. B., Khurana T. S., Therapeutics for Duchenne muscular dystrophy: current approaches and future directions Journal of Molecular Medicine 2004 82 2 102 115
165. Angelini C., Pegoraro E., Turella E., Intino M. T., Pini A., Costa C., Deflazacort in Duchenne dystrophy: study of long-term effect Muscle and Nerve 1994 17 4 386 391
166. Bonifati M. D., Ruzza G., Bonometto P., A multicenter, double-blind, randomized trial of deflazacort versus prednisone in duchenne muscular dystrophy Muscle and Nerve 2000 23 9 1344 1347
167. Partridge T. A., Morgan J. E., Coulton G. R., Hoffman E. P., Kunkel L. M., Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts Nature 1989 337 6203 176 179
168. Pault B., Rudnicki M., Torrente Y., Stem and progenitor cells in skeletal muscle development, maintenance, and therapy Molecular Therapy 2007 15 5 867 877
169. Gussoni E., Bennett R. R., Muskiewicz K. R., Long-term persistence of donor nuclei in a Duchenne muscular dystrophy patient receiving bone marrow transplantation Journal of Clinical Investigation 2002 110 6 807 814
170. Ebihara S., Guibinga G.-H., Gilbert R., Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice Physiological Genomics 2000 3 3 133 144
171. Smythe G. M., Hodgetts S. I., Grounds M. D., Problems and solutions in myoblast transfer therapy Journal of Cellular and Molecular Medicine 2001 5 1 33 47
172. Cerecedo D., Mondragon R., Candelario A., Utrophins compensate for Dp71 absence in mdx3cv in adhered platelets Blood Coagulation and Fibrinolysis 2008 19 1 39 47
173. Campbell K. P., Crosbie R. H., Utrophin to the rescue Nature 1996 384 6607 308 309
174. Tinsley J. M., Potter A. C., Phelps S. R., Fisher R., Trickett J. I., Davies K. E., Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene Nature 1996 384 6607 349 353
175. Odom G. L., Gregorevic P., Allen J. M., Finn E., Chamberlain J. S., Microutrophin delivery through rAAV6 increases lifespan and improves muscle function in dystrophic dystrophin/Utrophin-deficient mice Molecular Therapy 2008 16 9 1539 1545
176. Chaubourt E., Fossier P., Baux G., Leprince C., Israel M., De La Porte S., Nitric oxide and L-arginine cause an accumulation of utrophin at the sarcolemma: a possible compensation for dystrophin loss in Duchenne muscular dystrophy Neurobiology of Disease 1999 6 6 499 507
177. Barton E. R., Morris L., Kawana M., Bish L. T., Toursel T., Systemic administration of L-arginine benefits mdx skeletal muscle function Muscle and Nerve 2005 32 6 751 760
178. Voisin V., Sebrie C., Matecki S., L-arginine improves dystrophic phenotype in mdx mice Neurobiology of Disease 2005 20 1 123 130
179. Benabdellah F., Seyer A., Quinton L., Touboul D., Brunelle A., Laprvote O., Mass spectrometry imaging of rat brain sections: nanomolar sensitivity with MALDI versus nanometer resolution by TOF-SIMS Analytical and Bioanalytical Chemistry 2010 396 1 151 162
180. Hnia K., Gayraud J., Hugon G., L-arginine decreases inflammation and modulates the nuclear factor- B/matrix metalloproteinase cascade in Mdx muscle fibers American Journal of Pathology 2008 172 6 1509 1519
181. Chazalette D., Hnia K., Rivier F., Hugon G., Mornet D., 7B integrin changes in mdx mouse muscles after L-arginine administration FEBS Letters 2005 579 5 1079 1084
182. Deng B., Glanzman D., Tidball J. G., Nitric oxide generated by muscle corrects defects in hippocampal neurogenesis and neural differentiation caused by muscular dystrophy Journal of Physiology 2009 587 8 1769 1778
183. Khurana T. S., Rosmarin A. G., Shang J., Krag T. O. B., Das S., Gammeltoft S., Activation of utrophin promoter by heregulin via the ets-related transcription factor complex GA-binding protein / Molecular Biology of the Cell 1999 10 6 2075 2086
184. Krag T. O. B., Bogdanovich S., Jensen C. J., Heregulin ameliorates the dystrophic phenotype in mdx mice Proceedings of the National Academy of Sciences of the United States of America 2004 101 38 13856 13860
185. Kastin A. J., Akerstrom V., Pan W., Neuregulin-1- 1 enters brain and spinal cord by receptor-mediated transport Journal of Neurochemistry 2004 88 4 965 970
186. Chakkalakal J. V., Harrison M.-A., Carbonetto S., Chin E., Michel R. N., Jasmin B. J., Stimulation of calcineurin signaling attenuates the dystrophic pathology in mdx mice Human Molecular Genetics 2004 13 4 379 388
187. Miura P., Jasmin B. J., Utrophin upregulation for treating Duchenne or Becker muscular dystrophy: how close are we? Trends in Molecular Medicine 2006 12 3 122 129
188. St-Pierre S. J. G., Chakkalakal J. V., Kolodziejczyk S. M., Knudson J. C., Jasmin B. J., Megeney L. A., Glucocorticoid treatment alleviates dystrophic myofiber pathology by activation of the calcineurin/NF-AT pathway FASEB Journal 2004 18 15 1937 1939
189. Gramolini A. O., Jasmin B. J., Expression of the utrophin gene during myogenic differentiation Nucleic Acids Research 1999 27 17 3603 3609
190. Miura P., Chakkalakal J. V., Boudreault L., Pharmacological activation of PPAR / stimulates utrophin A expression in skeletal muscle fibers and restores sarcolemmal integrity in mature mdx mice Human Molecular Genetics 2009 18 23 4640 4649
191. Nelson S. F., Crosbie R. H., Miceli M. C., Spencer M. J., Emerging genetic therapies to treat Duchenne muscular dystrophy Current Opinion in Neurology 2009 22 5 532 538
192. Dunant P., Walter M. C., Karpati G., Lochmuller H., Gentamicin fails to increase dystrophin expression in dystrophin-deficient muscle Muscle and Nerve 2003 27 5 624 627
193. De Luca A., Nico B., Rolland J.-F., Gentamicin treatment in exercised mdx mice: identification of dystrophin-sensitive pathways and evaluation of efficacy in work-loaded dystrophic muscle Neurobiology of Disease 2008 32 2 243 253
194. Wagner K. R., Hamed S., Hadley D. W., Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations Annals of Neurology 2001 49 6 706 711
195. Du L., Damoiseaux R., Nahas S., Nonaminoglycoside compounds induce readthrough of nonsense mutations Journal of Experimental Medicine 2009 206 10 2285 2297
196. Welch E. M., Barton E. R., Zhuo J., PTC124 targets genetic disorders caused by nonsense mutations Nature 2007 447 7140 87 91
197. Hirawat S., Welch E. M., Elfring G. L., Safety, tolerability, and pharmacokinetics of PTC124, a nonaminoglycoside nonsense mutation suppressor, following single- and multiple-dose administration to healthy male and female adult volunteers Journal of Clinical Pharmacology 2007 47 4 430 444
198. Aartsma-Rus A., Fokkema I., Verschuuren J., Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations Human Mutation 2009 30 3 293 299
199. van Deutekom J. C., Janson A. A., Ginjaar I. B., Local dystrophin restoration with antisense oligonucleotide PRO051 The New England Journal of Medicine 2007 357 26 2677 2686
200. Kinali M., Arechavala-Gomeza V., Feng L., Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study The Lancet Neurology 2009 8 10 918 928
201. Moulton H. M., Wu B., Jearawiriyapaisarn N., Sazani P., Lu Q. L., Kole R., Peptide-morpholino conjugate: a promising therapeutic for duchenne muscular dystrophy Annals of the New York Academy of Sciences 2009 1175 55 60
202. Goyenvalle A., Vulin A., Fougerousse F., Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping Science 2004 306 5702 1796 1799
203. Goyenvalle A., Babbs A., van Ommen G.-J. B., Garcia L., Davies K. E., Enhanced exon-skipping induced by U7 snRNA carrying a splicing silencer sequence: promising tool for DMD therapy Molecular Therapy 2009 17 7 1234 1240
204. Wang C., Wang C.-M., Clark K. R., Sferra T. J., Recombinant AAV serotype 1 transduction efficiency and tropism in the murine brain Gene Therapy 2003 10 17 1528 1534
205. Burger C., Gorbatyuk O. S., Velardo M. J., Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system Molecular Therapy 2004 10 2 302 317